placeholder image
J. Vansteenkiste All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. 
    Lancet Oncology. 2018
  • Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. 
    New England Journal of Medicine. 2018
    • Contact
    full name
  • J. Vansteenkiste
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration